Dynamics of intact immunoglobulin G explored by drift-tube ion-mobility mass spectrometry and molecular modeling.

Collision cross-sections (CCS) of immunoglobulins G1 and G4 have been determined using linear drift-tube ion-mobility mass spectrometry. Intact antibodies and Fc-hinge fragments present with a larger range of CCS than proteins of comparable size. This is rationalized with MD simulations, which indicate significant in vacuo dynamics between linked folded domains. The IgG4 subclass presents over a wider CCS range than the IgG1 subclass.

[1]  J. Reichert.  Antibodies to watch in 2010 , 2010, mAbs.

[2]  A. Shvartsburg,et al.  An exact hard-spheres scattering model for the mobilities of polyatomic ions , 1996 .

[3]  L. Stryer,et al.  Correlation between segmental flexibility and effector function of antibodies , 1984, Nature.

[4]  Natalie J. Thompson,et al.  The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis. , 2013, Chemical communications.

[5]  Alain Van Dorsselaer,et al.  Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.

[6]  K. Roux,et al.  Flexibility of human IgG subclasses. , 1997, Journal of immunology.

[7]  P. Schnier,et al.  Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry. , 2010, Analytical chemistry.

[8]  P. Barran,et al.  Development of an ion mobility quadrupole time of flight mass spectrometer. , 2008, Analytical chemistry.

[9]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[10]  P. Parren,et al.  Species-Specific Determinants in the IgG CH3 Domain Enable Fab-Arm Exchange by Affecting the Noncovalent CH3–CH3 Interaction Strength , 2011, The Journal of Immunology.

[11]  John R. Engen,et al.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars , 2012, Nature Reviews Drug Discovery.

[12]  Thomas M. Dillon,et al.  Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass* , 2008, Journal of Biological Chemistry.

[13]  M. Kwiatkowski,et al.  Mass spectrometric analysis of protein species of biologics , 2013 .

[14]  M. Gross,et al.  Complementary MS Methods Assist Conformational Characterization of Antibodies with Altered S–S Bonding Networks , 2013, Journal of The American Society for Mass Spectrometry.

[15]  T. Rispens,et al.  Human IgG4 Binds to IgG4 and Conformationally Altered IgG1 via Fc-Fc Interactions , 2009, The Journal of Immunology.

[16]  Christian Bailly,et al.  Strategies and challenges for the next generation of therapeutic antibodies , 2010, Nature Reviews Immunology.

[17]  A. Ashcroft,et al.  The role of ion mobility spectrometry-mass spectrometry in the analysis of protein reference standards. , 2013, Analytical chemistry.

[18]  T. Wyttenbach,et al.  Effect of the long-range potential on ion mobility measurements , 1997 .

[19]  L. J. Harris,et al.  Refined structure of an intact IgG2a monoclonal antibody. , 1997, Biochemistry.

[20]  L J Harris,et al.  Crystallographic structure of an intact IgG1 monoclonal antibody. , 1998, Journal of molecular biology.

[21]  Martin F. Jarrold,et al.  Structural Information from Ion Mobility Measurements: Effects of the Long-Range Potential , 1996 .

[22]  François Debaene,et al.  Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. , 2013, Analytical chemistry.

[23]  S. Morrison,et al.  Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. , 1988, The EMBO journal.

[24]  P. Rios,et al.  Freezing immunoglobulins to see them move. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2010 , 2010, Nature Biotechnology.

[26]  I. Sandlie,et al.  The structural requirements for complement activation by IgG: does it hinge on the hinge? , 1995, Immunology today.

[27]  B. Matthews.  Solvent content of protein crystals. , 1968, Journal of molecular biology.

[28]  Bernhard Rupp,et al.  Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein–nucleic acid complex crystals , 2003, Protein science : a publication of the Protein Society.